Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Recombinant Human Interferon α2b for Injection

Approval Number

国药准字S20010043

Company长春生物制品研究所有限责任公司

Registration Date

August 31, 2020

Previous Approval Numbers

国药准字S20010043

Drug Information

Generic Name

注射用重组人干扰素α2b

Trade Name

长生扶康

Brand Name

长生扶康

Dosage Form

冻干粉针剂

Strength

500万IU

Drug Type

生物制品

Registration Date

August 31, 2020

Company Information

Applicant Company

Company Name长春生物制品研究所有限责任公司

Company Address

长春市高新技术开发区创新路1616号

Manufacturing Company

Company Name长春生物制品研究所有限责任公司

Company Address

长春市高新技术开发区创新路1616号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用重组人干扰素α2b - NMPA 批准文号 | MedPath